Friedberg Ezra M 4
4 · Pelthos Therapeutics Inc. · Filed Apr 6, 2026
Research Summary
AI-generated summary of this filing
Pelthos (PTHS) Director Ezra Friedberg Sells Shares
What Happened
Ezra M. Friedberg, a director of Pelthos Therapeutics, sold a total of 558 shares of Pelthos common stock in open-market transactions on April 2, 2026. The sales were in two blocks: 293 shares at a weighted-average price of $20.51 for proceeds of $6,010, and 265 shares at a weighted-average price of $21.36 for proceeds of $5,661 — about $11,671 total. These were sales (S), not purchases.
Key Details
- Transaction date: April 2, 2026; Form 4 filed April 6, 2026 (timely — within two business days).
- Reported prices and execution details:
- 293 shares sold at a weighted avg of $20.51 (executed in multiple trades at $20.30–$20.78).
- 265 shares sold at a weighted avg of $21.36 (executed in multiple trades at $21.31–$22.03).
- Shares owned after transaction: Not specified in the provided excerpt of the filing.
- Footnotes of note:
- Sale made pursuant to a Rule 10b5-1 trading plan adopted Dec 16, 2025 to satisfy estimated tax obligations related to RSU vesting. (F1)
- Weighted-average prices reported; the filer will provide full trade-level details on request. (F2, F3)
- Mr. Friedberg is manager of two LLCs that hold shares; he may be deemed beneficial owner of those record holdings but disclaims beneficial ownership except for his pecuniary interest. (F4)
Context
A Rule 10b5-1 plan is a prearranged trading plan that allows insiders to sell shares at set times or under predetermined conditions; such sales are often routine (for example, to cover tax withholding on vested awards) and do not necessarily reflect the insider’s view of the company. Sales (S) are generally less informative about insider sentiment than purchases, which can be a stronger bullish signal.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-04-02$20.51/sh−293$6,010→ 82,292 total - Sale
Common Stock
[F1][F3]2026-04-02$21.36/sh−265$5,661→ 82,027 total
- 82,072(indirect: By LLC)
Common Stock
[F4] - 40,000(indirect: By LLC)
Common Stock
[F4]
Footnotes (4)
- [F1]This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
- [F2]This transaction was executed in multiple trades at prices ranging from $20.30 to $20.78. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $21.31 to $22.03. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.